Bayer

[video] Onyx Pharma CEO on New Cancer Drug
CNBC
Mon, 06/4/12 - 05:57 pm
ONYX Pharmaceuticals
Anthony Coles
Bayer
regorafenib
gastrointestinal cancer
Buy This Pharma Giant Now For A 30% Return In 2013
Seeking Alpha
Wed, 05/30/12 - 03:04 pm
JNJ
Bayer
Pfizer
Ranbaxy
Bristol-Myers Squibb
Ardea Biosciences gets $7.5M payment as Bayer starts clinical trial of cancer drug candidate
Yahoo/AP
Wed, 05/30/12 - 11:17 am
Ardea
Bayer
BAY 96-9766
ASCO Stocks To Consider This Week
Seeking Alpha
Tue, 05/29/12 - 11:15 am
ASCO
Arena Pharmaceuticals
Vivus
JNJ
Bayer
Onyx
Pharmacyclics
Nexavar: Are 3 Failed Phase 3 Trials Enough?
Motley Fool
Thu, 05/24/12 - 10:13 am
Bayer
Onyx
Nexavar
lung cancer
Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Yahoo/AP
Tue, 05/22/12 - 09:42 am
Bayer
Onyx
Nexavar
lung cancer
Your Warning Label Is My Sales Brochure
Motley Fool
Thu, 05/17/12 - 10:20 am
warnings
MS
Gilenya
multiple sclerosis
Novartis
Biogen Idec
Bayer
Teva Pharmaceuticals
Elan
Pfizer
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Using lucrative strategy, Johnson & Johnson seeks fifth use of anticlotting drug
Yahoo/AP
Thu, 05/10/12 - 11:00 am
Bayer
JNJ
Xarelto
bloodthinners
J&J seeks Xarelto approval to prevent stent clots
Reuters
Wed, 05/9/12 - 10:20 am
stents
JNJ
Xarelto
Bayer
Bayer appeals India patent office ruling
MarketWatch
Sat, 05/5/12 - 04:58 pm
Bayer
patents
Nexavar
generics
Diving for Dividend Growth in Big Pharma
Motley Fool
Fri, 05/4/12 - 10:40 am
dividends
GSK
Novartis
AstraZeneca
Sanofi
Abbott Laboratories
Roche
Bayer
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Piramal buys Bayer molecular imaging portfolio
Yahoo/AP
Mon, 04/16/12 - 11:24 am
Bayer
molecular imaging
Piramal Healthcare
FDA adds clotting data to Bayer's Yaz, Yasmin
Fierce Pharma
Thu, 04/12/12 - 12:25 pm
Bayer
FDA
Yaz
Yasmin
birth control pill
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Yahoo/Fly on the Wall
Tue, 04/3/12 - 10:12 am
ONYX Pharmaceuticals
regorafenib
GIST
Bayer
Bayer Says Drug Held Off Gastrointestinal Tumors in Study
Bloomberg
Tue, 04/3/12 - 08:57 am
gastrointestinal cancer
Bayer
regorafenib
Merck: Now A Compelling 'Buy' Candidate
Seeking Alpha
Mon, 04/2/12 - 11:58 am
Merck
M&A
Bayer
GSK
Pfizer
China Biotech In Review: GE Seeks To Increase China Revenues By Expanding Beyond Top Tier Markets
Seeking Alpha
Sun, 04/1/12 - 11:46 am
Chongqing Huapont Pharma
RegeneRx
GSK
Hanmi Pharma
Hubei Minkang Pharma
Bayer
GE Healthcare
Roche
Big Pharma Cozies Up to Biotech
Motley Fool
Sat, 03/31/12 - 12:20 pm
JNJ
Bayer
GSK
Eli Lilly
Merck
Biogen Idec

Pages